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Study objectives: Surgical lung biopsy (SLB) plays an important role in the diagnosis
of interstitial pneumonia, however, the occurrence of acute respiratory failure
following SLB remains largely unreported. We evaluated the incidence, clinical
features, therapy and prognosis of acute exacerbation of interstitial pneumonia
following SLB.
Design: Retrospective study of consecutive patients who underwent SLB to establish
a diagnosis of diffuse lung disease between May 1989 and April 2000. Patients with an
acute exacerbation following lung biopsy were studied, and the HRCT images of the
chest before and after surgery were reviewed.
Measurements and results: Among the 236 consecutive patients with interstitial
pneumonia who underwent a surgical lung biopsy, five (2.1%) (IPF, 3; NSIP, 1; COP, 1)
developed acute exacerbation of the diffuse lung disease in the course of 1–18 days
after SLB. The extent of parenchymal involvement on HRCT before surgery wasElsevier Ltd. All rights reserved.
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Y. Kondoh et al.1754not significantly different between operated and contralateral nonoperated lung.
Significantly increased regions of parenchymal involvement on HRCT were seen
postoperatively compared with the preoperative CT in both the operated
(20.7712.5% versus 38.2710.8%, P ¼ 0:0431) and nonoperated lung (22.7713.8%
versus 70.5724.4%, P ¼ 0:0431), but the extent of the parenchymal involvement
was significantly greater on the nonoperated side (P ¼ 0:0251). Two of the 3 IPF
patients died from the acute exacerbation.
Conclusions: It is important to be aware of the possibility of acute exacerbation of
interstitial pneumonia following SLB even after an apparently uneventful immediate
postoperative course. The asymmetric image findings suggest that intraoperative
respiratory management is a possible etiologic factor.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Surgical lung biopsy (SLB) plays an important role in
the diagnosis of interstitial pneumonia.1 Although it
is considered to be a relatively safe surgical pro-
cedure, the mortality from SLB has been reported
to range between 0% and 12%2 including patients in
whom respiratory failure occurred following SLB.3,4
Nishiyama et al.4 reported the case history of a
patient with idiopathic pulmonary fibrosis (IPF) who
deteriorated after SLB. Utz et al.3 reported that 2
IPF/UIP patients died within 30 days of biopsy
because of acute pulmonary edema or acute
respiratory distress syndrome (ARDS) among their
patients with UIP; we suspect that acute exacer-
bation occurred postoperatively in these patients.
However the occurrence of acute respiratory fail-
ure following SLB remains largely unreported.
In contrast with acute exacerbation following
SLB, ARDS following pulmonary resection for lung
cancer has long been known.3–9 The recent report
of Padley et al.10 demonstrated by the use of CT
values that ARDS following lung resection was
asymmetric, occurring mainly in the nonoperated
lung. This led us to the hypothesis that acute
exacerbation following SLB, which is less invasive
than pulmonary resection for lung cancer, could
occur mainly in the nonoperated lung.
Recently, we have encountered several patients
with interstitial lung disease who suffered acute
exacerbation following SLB. Herein, we report the
incidence, clinical features, therapy and prognosis.
We also evaluated asymmetry of acute exacerba-
tion by the use of chest CT.Methods
Of 236 consecutive patients who underwent surgi-
cal lung biopsy (99 ¼ open; 137 ¼ thoracoscopic) to
help establish a diagnosis of diffuse lung disease atTosei General Hospital, Nagoya University Hospital,
Toyohashi City Hospital, Kariya General Hospital,
Komaki City Hospital, and Handa City Hospital
between May 1989 and April 2000, five patients
presented with an acute exacerbation following
lung biopsy. By October 2002, all SLB specimens
were reviewed by 2 pathologists (T.Y., M.K.)
according to the currently redefined criteria for
idiopathic interstitial pneumonias.1 A retrospective
investigation was undertaken of case histories,
anesthesiology records, and image findings. Cases
with clear postoperative complications, such as
pneumonia, heart failure, hemothorax or pulmon-
ary hemorrhage were excluded. One of the five
cases was previously reported.4 This study was
approved by our institutional review boards, and
informed consent was obtained from the patients
or the next of kin.
All patients had examination of thin-slice CT of
the chest before and after surgery, the latter during
the acute exacerbation. The CT scans comprised
2.0-mm collimation sections, reconstructed with
the use of a high-spatial-frequency algorithm. The
CT scans were performed with a variety of
scanners. None of the patients received intrave-
nous contrast medium.
The CT images were reviewed independently by
two observers (Y.K., T.J.) according to the method
of Ichikado et al.11 These observers did not know
any of the patients’ clinical information. The lungs
were divided into three zones (upper, middle, and
lower); each zone was evaluated separately. Each
of the three zones corresponded to approximately
one-third of the images from the lung apex to 1 cm
below the domes of the diaphragm. In each
patient, corresponding zones of CT were selected
before and after surgery.
The observers assessed the extent of total paren-
chymal involvement independently for each of the
three zones of each lung. The total parenchymal
involvement meant areas with various findings
including ground-glass attenuation, consolidation,
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thickening, and honeycombing, The CT score in the
upper, middle, and lower lung zones was determined
visually and was estimated to the nearest 10% of
parenchymal involvement. Overall percentage of
involvement was obtained by averaging the six lung
zones. The final total parenchymal involvement was
obtained by averaging the scores of the two observers.
Statistical examination
The interobserver variation of the extent of
parenchymal involvement was evaluated with the
Spearman’s rank correlation coefficient, and the
differences were evaluated by Bland-Altman
plots.12 Wilcoxon test and repeated measures
two-ways analysis of variance were used to
evaluate trends of parenchymal involvement on
CT. A P value of less than 0.05 was considered to
indicate a statistically significant difference.Results
Clinical features of acute exacerbation
The incidence of postoperative exacerbation was 2.1%
(5/236 patients). The exacerbation occurred withinTable 1 Clinical Data on admission of the five patient
biopsy.
Case 1 Case 2
Histologic diagnosis UIP UIP
Age (yr) 60 69
Sex M M
Duration of symptom (mo) 24 18
Smoking (Pack-years) Current
smoker (60)
Ex-smo
(150)
WBC (ml) 7500 6000
CRP (mg/dl)* 1.7 0.1
ANA NEG NEG
RF NEG NEG
VC (% predicted) 75.4 49.8
DLco (% predicted) 57.1 47.1
PaO2 (mmHg), on air 58.2 80.0
BALF
Cell counts ( 104/ml) 44.3 21.4
% Macrophages 78.0 96.0
% Neutrophils 14.7 1.0
% Lymphocytes 7.3 2.7
% Eosinophils 0 0.3
Definition of abbreviations: UIP ¼ usual interstitial pneumonia,
pneumonia, M ¼ male, F ¼ female, CRP ¼ C-reactive protein
POS ¼ positive, ANA ¼ anti-nuclear antibody, RF ¼ rheumatoid
fluid.48h in 2 patients and between 48h and 18 days in 3
patients. Postoperative exacerbation occurred in 3 of
80 (3.8%) IPF patients, in 1 of 28 (3.8%) NSIP patients,
and in 1 (9.1%) of 11 COP patients.
Table 1 shows clinical data of the five patients on
admission. None of these patients had shown
accelerated decline before SLB. Although the blood
gas analysis and pulmonary function test findings of
case 3 did not indicate significant impairment, we
diagnosed this case as IPF based on radiological and
pathologic findings.
Table 2 shows the times of surgical procedure,
anesthesia and FiO2 1.0, the interval between
surgery and exacerbation, test findings at the time
of exacerbation, and gas exchange findings for the
five patients who experienced exacerbation. None
of these patients had received blood transfusion or
had other factors known to induce ARDS. BALF
findings of 3 patients for the nonoperated lung at
the time of exacerbation showed a significant
increase in neutrophil fraction compared to the
preoperative findings (Tables 1 and 2). Neither
cultures of sputum, blood, BALF and urine for
bacteria, viruses, mycobacteria, and fungi nor
clinical features including serum titers against
Mycoplasma, Legionella and viruses revealed any
infectious events which could be responsible for
the deterioration.s who showed acute exacerbation after surgical lung
Case 3 Case 4 Case 5
UIP NSIP OP
59 74 67
M M F
4 5 5.5
ker Current
smoker (20)
Ex-smoker
(53)
Nonsmoker
(0)
6900 8900 7800
— 0.2 0.1
NEG NEG NEG
NEG POS NEG
91.9 59.8 91.5
117.0 35.5 91.0
92.2 63.7 76.0
30.0 33.0 21.0
86.0 26.2 30.0
0 6.1 0
14.0 67.7 66.4
0 0 0
NSIP ¼ nonspecific interstitial pneumonia, OP ¼ organizing
, *normal range; less than 0.7mg/dl, NEG ¼ negative,
factor, VC ¼ vital capacity, BALF ¼ broncho-alveolar lavage
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Table 2 Surgical data, clinical data, and BALF findings at exacerbation.
Case 1 Case 2 Case 3 Case 4 Case 5
Histologic diagnosis UIP UIP UIP NSIP OP
Surgical time (m) 54 80 79 40 55
Anesthesia time (m) 185 195 131 180 190
FIO2 1.0 time (m) 80 120 NA 40 170
Time from surgery until
exacerbation (days)
6 14 1 18 2
WBC (ml) 9000 13,100 7100 9800 11,000
CRP (mg/dl)* 9.0 3.8 2.0 17.0 10.8
PaO2 (mmHg) 58.2 80.0 92.2 63.7 56.0
FiO2 0.6 1.0 0.4 0.8 1.0
PaO2/FiO2 99 233 189 63 137
BALF
Cell counts ( 104/ml) 19.1 8.8 NA 14.0 NA
% Macrophages 34.3 50.7 NA 39.3 NA
% Neutrophils 59.7 49.0 NA 35.7 NA
% Lymphocytes 1.0 0.3 NA 21.4 NA
% Eosinophils 5.0 0.0 NA 3.6 NA
Definition of abbreviations: CRP ¼ C-reactive protein, NA ¼ not available, BALF ¼ broncho-alveolar lavage fluid, *normal range;
less than 0.7mg/dl.
Y. Kondoh et al.1756Radiologic findings of acute exacerbation
There was good interobserver agreement for the
extent of lung involvement on HRCT (r ¼ 0:956;
Po0:001). Bland-Altman plots for the extent of
parenchymal involvement showed good interobserver
agreement (mean difference was 5.7 and the limits
of agreement between two observers in each patient
ranged from 13.6 to 11.6, which fell within the
mean71.96 SD). The extent of parenchymal involve-
ment on HRCT before surgery was not significantly
different between operated and nonoperated lung
(20.7712.5% versus 22.7713.8%). HRCT at acute
exacerbation after SLB revealed extensive shadows
on the nonoperated lung in all patients, except 1
patient who showed increasing involvement in both
lungs without predominance. Significantly increased
regions of the parenchymal involvement on HRCT
were seen postoperatively compared with the pre-
operatively CT in both the operated (20.7712.5%
versus 38.2710.8%, P ¼ 0:0431) and nonoperated
lung (22.7713.8% versus 70.5724.4%, P ¼ 0:0431),
but the extent of the parenchymal involvement was
significantly greater on the contralateral side
(P ¼ 0:0251) (Figs. 1(a–d) and 2).Treatment and prognosis of acute
exacerbation
The postoperative treatment is shown in Table 3.
All patients were treated with broad-spectrumantibiotics and corticosteroids. Three received
intravenous corticosteroid pulse therapy (methyl-
prednisolone 1 g/day for three days) followed by a
tapered dose, three received methyl-prednisolone
2mg/kg/day for 2 weeks followed by a tapered
dose which had been reported effective for the
fibroproliferative phase of ARDS,13 and one re-
ceived both therapies. Immunosuppressants were
introduced in three patients: cyclophosphamide in
one and cyclosporine A in two. Two of the three IPF
patients needed invasive mechanical ventilation.
One patient died 1 month after surgical lung biopsy
due to respiratory failure. Another patient im-
proved from acute exacerbation but his respiratory
failure progressed slowly, and finally died five
months after SLB. Of the remaining three patients,
one required invasive mechanical ventilation man-
agement and two required noninvasive positive
pressure ventilation (NPPV). All three remain alive
(mean follow up duration, 58.7 months; range,
38–76).Discussion
The present study has demonstrated that post-
biopsy exacerbation occurred in 2.1% of 236
consecutive patients undergoing surgical biopsy
for diffuse lung disease. Acute exacerbation
occurred from immediately following surgery to
2–3 weeks postoperatively. It is noteworthy that
exacerbation can occur 2–3 weeks postoperatively
ARTICLE IN PRESS
Figure 1 A 60-year-old man with IPF who underwent left-sided surgical biopsy. (A) Chest radiograph before surgical
lung biopsy (SLB) shows predominantly peripheral, bilateral lower zone reticular shadows. (B) Chest radiograph
obtained 5 days after SLB shows bilateral ground glass changes and consolidation, predominantly in the nonoperated
lung. (C) CT scan of the lower lobes before surgical lung biopsy (SLB) shows peripheral bilateral reticular change. (D) CT
scan of the lower lobes obtained 5 days after SLB shows enhanced ground glass change and consolidation affecting the
nonoperated lung.
Figure 2 Quantification of extent of lung involvement
pre- and postbiopsy in the operated and nonoperated
lungs (filled circles, nonoperated lung; open circles,
operated lung). Regions of significantly increased density
were seen pre- and postoperatively in both the operated
(20.7712.5% versus 38.2710.8%, P ¼ 0:0431) and non-
operated lung (22.7713.8% versus 70.5724.4%,
P ¼ 0:0431), but the extent of the elevation of the CT
density was significantly greater on the nonoperated side
(P ¼ 0:0251).
Acute exacerbation of interstitial pneumonia 1757even when the short-term course after operation is
favorable.
In the present study, none of the patients with
IPF who experienced acute exacerbation,14,15 hadan accelerated decline or subacute course before
SLB. The outcome of acute exacerbation in IPF
was poor: 2 of 3 patients died. Recently, Ultz
et al. reported that 2 IPF/UIP patients died from
ARDS or other respiratory failure within 30 days of
surgical lung biopsy,3 and we suspect that acute
exacerbation occurred postoperatively in these
patients. Special attention needs to be paid to
the possibility of postsurgical acute exacerbation
of IPF.
BALF findings for the nonoperated lung in 3
patients at the time of postbiopsy exacerbation
showed a significant increase in neutrophil fraction
compared with preoperative findings. Therefore,
acute exacerbation after SLB may involve neutro-
philic lung injury although it could simply reflect a
widespread increase of capillary permeability.
It is worth noting that while in many cases
infiltrates appeared in both the operated and
nonoperated lung in this study, four of 5 cases
showed more conspicuous abnormalities on the
nonoperated side. This finding is compatible with
the report of Padley et al., who demonstrated an
asymmetric form of ARDS following pulmonary
resection.10 Thought must be given, therefore, to
factors that can explain the contra-lateral exacer-
bation.
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Table 3 Therapy and outcome of the five patients with post-biopsy acute exacerbation.
Case 1 Case 2 Case 3 Case 4 Case 5
Histologic diagnosis UIP UIP UIP NSIP OP
IPPV + +  + 
NPPV  +   +
Corticosteroid + + + + +
Pulse therapy + + +  
Two mg/kg/day followed by a tapered
dosage
 +  + +
Immunosuppressant + +   +
Outcome Died at 6
mo
Died at 1
mo
Alive at 78
mo
Alive at 62
mo
Alive at 38
mo
Definition of abbreviations: IPPV ¼ invasive positive pressure ventilation, NPPV ¼ noninvasive positive pressure ventilation,
Pulse therapy ¼ methylprednisolone 1 g/kg/day, for 3 days.
Y. Kondoh et al.1758Compared with acute exacerbation following lung
biopsy, ARDS following pneumonectomy or lobect-
omy for lung carcinoma has been well recognised.5,9
High concentrations of inspired oxygen associated
with single-lung ventilation or ischemic/reperfusion
injury are thought to cause acute lung injury.16,17
The technique of single-lung ventilation is per-
formed in most surgical lung biopsies. During
surgery, the contralateral lung remains ventilated
and serves as the source of maintained patient
oxygenation. If lung injury is caused at this time, the
contralateral lung may be more adversely affected
postoperatively. Because oxygenation is impaired
during single-lung ventilation by the physiological
shunt effect of the collapsed lung undergoing the
biopsy procedure, a high concentration of inspired
oxygen might have to be used. In some cases, a high
airway pressure and tidal volume also might be
used. In this regard, the patients in the present
study who experienced postoperative exacerbation
had received 100% oxygen ventilation for 40–170min
during surgery. Unfortunately intraoperative tidal
volume could not be confirmed from anesthesia
records. Because PaCO2 was kept at nearly the
normal range in blood gas during surgery, it would
not be possible that tidal volume was limited.
In recent years, lung damage resulting from
ventilator management (ventilator-induced lung
injury; VILI) has been shown in animal experi-
ments.18 Ventilator associated lung injury (VALI)
has also been demonstrated clinically.19 Factors in
VALI are presumed to include oxygen toxicity due to
100% oxygen inhalation20 and increased tidal
volume, and shear stress caused by repeated
alveolar collapse and opening. Based on the fore-
going, we speculated that the main cause of
postoperative exacerbation is ventilator associated
lung injury that was caused by intraoperative
respiratory management.The frequency of ALI and ARDS after lung
resection has been reported to be related to the
extent of resection; the highest frequency was
observed after extensive resection (12.9%), fol-
lowed by pneumonectomy (6.0%), lobectomy
(3.7%), and minor resection (1.0%).17 Accordingly,
despite the lower surgical invasiveness of biopsy
than in this study, the frequency of postoperative
exacerbation following SLB was 2.1%. Further
studies are needed to determine whether underling
interstitial pneumonia enhances the risk of acute
lung injury following pulmonary resection. It is also
notable that 3/5 patients survived acute exacer-
bation. While numbers are too small to be
definitive, this outcome appears better than that
seen in spontaneous acute exacerbation and may
reflect a response to corticosteroid therapy.
In summary, we report acute exacerbation follow-
ing surgical lung biopsy in consecutive 236 patients
with interstitial pneumonia. When surgical lung
biopsy is performed in cases of interstitial pneumo-
nia, it is important to be aware of the possibility of
postoperative acute exacerbation, even after an
apparently uneventful immediate postoperative
course. After exclusion of other possible causes of
deterioration, especially infection, this diagnosis
should be considered and would then allow the early
institution of corticosteroid therapy. While the
present study was not designed to elucidate the
cause, the asymmetric image findings suggest that
intraoperative respiratory management is one pos-
sibility. This requires further study.Acknowledgement
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